ADHS und Sucht: erste Erfahrungen in der Behandlung mit Atomoxetin

Zusammenfassung

ADHS im Erwachsenenalter ist mit einem erhöhten Risiko der Entwicklung einer Suchstörung assoziiert. Wegen dem Suchtpotential von Methylphenidat wird die Behandlung mit Atomoxetin bei Suchtpatienten mit ADHS diskutiert. Anhang von zwei Fällen werden erste Erfahrungen beschrieben. Zukünftige Studien auch bezüglich der Dosierung sind notwendig.

Abstract

The adult form of ADHD is associated with a higher risk of developing a substance use disorder (SUD). Due to the addictive potential of methylphenidate, treatment with atomoxetine is discussed for patients with SUD and ADHD, and two cases are presented. Future studies, also with regard to dosage, are needed.

ADHS - Atomoxetin - Sucht

ADHD - atomoxetine - addiction

Literatur

• 1 Spencer T. Is attention-deficit hyperactivity disorder in adults a valid disorder?.  Harvard Rev Psychiatry. 1994;  1 326-335
• 2 American Psychiatric Association .Diagnostic and Statistical Manual of Mental Disorders. Washington DC; APP 1987
• 3 Krause K H, Krause J, Trott G E. Das hyperkinetische Syndrom (Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung) im Erwachsenenalter.  Nervenarzt. 1998;  69 543-556
• 4 Wender P H. The diagnosis and treatment of attention-deficit hyperactivity disorder in adults. Dunner DL Current psychiatric therapy Philadelphia, London, Toronto; Saunders 1993: 489-493
• 5 American Psychiatric Association .Diagnostic and statistical manual of mental disorders (DSM IV). Washington DC; APP 1994
• 6 Manuzza S, Klein R G, Bessler A. et al . Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.  Arch Gen Psychiatry. 1993;  50 565-567
• 7 Rasmussen P, Gillberg C. Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study.  J Am Acad Child Adolesc Psychiatry. 2000;  39 1424-1431
• 8 Steinhausen H C. Attention-deficit hyperactivity disorder in a life perspective.  Acta Psych Scand. 2003;  107 321-322
• 9 Weiss G, Hechtman L, Milroy T. et al . Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children.  J Am Acad Child Adolesc Psychiatry. 1985;  24 211-223
• 10 Barkley R A. Attention deficit hyperactivity disorder: long term course, adult outcome, and comorbid disorder. NIH Consensus Development Conference: Diagnosis and Treatment of Attention Deficit Disorder. Washington DC; NIH-Press 1998: 57-59
• 11 Krause J, Krause K H. ADHS im Erwachsenenalter. Die Aufmerksamkeits-/Hyperaktivitätsstörung bei Erwachsenen. Stuttgart, New York; Schattauer 2003
• 12 Retz-Junginger P, Retz W, Blocher D. et al . Wender Utah Rating Scale (WURS-k).  Nervenarzt. 2002;  73 830-838
• 13 Rösler M, Retz W, Retz-Junginger P. et al . Instrumente zur Diagnostik der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Erwachsenenalter.  Nervenarzt. 2004;  75 888-895
• 14 Conners C K, Erhardt D, Sparrow E. Conner’s Adult ADHD Rating Scales (CAARS). North Tonawanda, NY; Multi-Health Systems 1999
• 15 Brown T E. Brown attention deficit disorder scales. San Antonio, TX; Psychol Corp 1996
• 16 Kessler R C, Adler L, Ames M. et al . The World Health Organisation adult ADHD self-report scale (ASRS): a short screening scale for use in the general population.  Psychol Medicine. 2005;  35 245-256
• 17 Manuzza S. et al . Hyperactive boys almost grown up: V. Replication of psychiatric status.  Arch Gen Psychiatry. 1991;  48 77-83
• 18 Wilens T. et al . Comorbidity of attention deficit hyperactivity and psychoactive substance use disorder.  Hosp Commun Psychiatry. 1994;  45 421-435
• 19 Schubiner H, Tzelepis A, Milberger S. et al . Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers.  J Clin Psychiatry. 2000;  61 244-251
• 20 Wilens T E. AOD use and attention-deficit/hyperactivity disorder.  Alcohol Health Res World. 1998;  22 127-130
• 21 Biedermann J, Wilens T, Mick E. Is ADHD a risk factor for psychoactive substance use disorder? Findings from a four-year prospective follow-up-study. J Am Child Adolesc Psychiatry 1997 36: 21-29
• 22 Shekim W O, Asarnow R F, Hess E. A clinical and demographic profile of a sample of adults with attention deficit hyperacticity disorder, residual state.  Compr Psychiatry. 1990;  31 416-425
• 23 Gittelman R. et al . Hyperactive boys almost grown up: I. Psychiatric status.  Arch Gen Psychiatry. 1985;  42 937-947
• 24 Wilens T E, Biederman J, Mick E. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders.  J Nerv Ment Dis. 1997;  185 475-482
• 25 Wilens T E, Biederman J, Mick E. Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD.  Am J Addict. 1998;  7 156-163
• 26 Wilens T E. Impact of ADHD and its Treatment on Substance Abuse in Adults.  J Clin Psychiatry. 2004;  65 38-45
• 27 Carroll K M. et al . Psychotherapy and pharmacotherapy for ambulatory cocaine abusers.  Arch Gen Psychiatry. 1994;  51 177-187
• 28 Rounsaville B J. et al . Psychiatric diagnoses of treatment-seeking cocaine abusers.  Arch Gen Psychiatry. 1991;  48 43-51
• 29 Carroll K M. et al . History and significance of childhood attention-deficit hyperactivity disorder in treatment-seeking cocaine abusers.  Compr Psychiatry. 1993;  34 75-82
• 30 Arnsten A FT. Dopaminergic and noradrenergic influences on cognitive functions mediated by prefrontal cortex. Solanto MV, Arnsten AFT, Castellanos FX Stimulant Drugs and ADHD. Basic and Clinical Neuroscience New York; Oxford University Press 2001: 185-208
• 31 Banaschewski T, Brandeis D, Heinrich H. et al . Association of ADHD and conduct disorder - brain electrical evidence for the existence of a distinct subtype.  J Child Psychol Psychiatry. 2003;  44 356-376
• 32 Banaschewski T, Brandeis D, Heinrich H. et al . Questioning inhibitory control as the specific deficit of ADHD - evidence from brain electrical activity.  Journal of Neural Transmission Online. 2003; 
• 33 Brandeis D, Banaschewski T, Baving L. et al . Multicenter P300 brain mapping of impaired attention to cues in hyperkinetic children.  J Am Acad Child Adolesc Psychiatry. 2002;  41 990-998
• 34 Castellanos F X, Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nature reviews.  Neuroscience. 2002;  3 617-628
• 35 Faraone S V, Biederman J. Pathophysiology of Attention Deficit Hyperactivity Disorder. Davis K, Charney D, Coyle JT, Nemeroff C ACNP’s Fifth Generation of Progress New York; Lipponcott, Williams and Wilkens 2002: 577-596
• 36 Spencer T, Biederman J, Wilens T. et al . Pharmacotherapy of attention deficit hyperactivity disorder across the life cycle.  J Am Acad Child Adolesc Psychiatry. 1996;  35 409-432
• 37 Gawin F. et al . Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report.  Am J Drug Alc Abuse. 1985;  11 193-197
• 38 Grabowski J, Roache J D, Schmitz J M. Replacement medication for cocaine dependence: methylphenidate.  J Clin Psychopharmacology. 1997;  17 485-488
• 39 Wilens T E, Faraone S V, Biederman J. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.  Pediatrics. 2003;  111 179-185
• 40 Witcher J W, Long A, Smith B. et al . Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder.  J Child Adolesc Psychopharmacol. 2003;  13 53-63
• 41 MTA-Cooperative-Group .A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999 56: 1073-1086
• 42 Kratochvil C J, Heiligenstein J H, Dittmann R. et al . Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.  J Am Acad Child Adolesc Psychiatry. 2002;  41 776-784
• 43 Spencer T, Heiligenstein J H, Biederman J. et al . Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.  J Clin Psychiatry. 2002;  63 1140-1147
• 44 Heil S H, Holmes H W, Bickel W K. Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users.  Drug Alcohol Depend. 2002;  67 149-156